GE HEALTHCARE TECHNOLOGIES INC(GEHC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GEHC GE HEALTHCARE TECHNOLOGIES INC

盘后交易 07-14 18:14:37 EDT

61.66

-3.65

-5.59%

盘后61.83

+0.17+0.28%

18:11 EDT

最高63.72	最低60.53	成交量1,214万
今开63.51	昨收65.31	日振幅4.88%
总市值280.87亿	流通市值280.73亿	总股本4.56亿
成交额7.46亿	换手率2.67%	流通股本4.55亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GEHC","market":"US","secType":"STK","nameCN":"GE HEALTHCARE TECHNOLOGIES INC","latestPrice":61.66,"timestamp":1784059200000,"preClose":65.31,"halted":0,"volume":12140309,"hourTrading":{"tag":"盘后","latestPrice":61.83,"preClose":61.66,"latestTime":"18:11 EDT","volume":1869908,"amount":114965930.48385601,"timestamp":1784067070096,"change":0.17,"changeRate":0.002757,"amplitude":0.002757},"delay":0,"changeRate":-0.055887306691165296,"floatShares":455283435,"shares":455521592,"eps":4.17001,"marketStatus":"盘后交易","change":-3.65,"latestTime":"07-14 18:14:37 EDT","open":63.505,"high":63.72,"low":60.53,"amount":746357473.348906,"amplitude":0.048844,"askPrice":62.25,"askSize":50,"bidPrice":61.81,"bidSize":3,"shortable":3,"etf":0,"ttmEps":4.17001,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1784073600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":65.31,"dividendRate":0.002271,"preHourTrading":{"tag":"盘前","latestPrice":63.51,"preClose":65.31,"latestTime":"09:29 EDT","volume":21539,"amount":1373974.231574,"timestamp":1784035799999,"change":-1.8,"changeRate":-0.027561,"amplitude":0.033685},"postHourTrading":{"tag":"盘后","latestPrice":61.83,"preClose":61.66,"latestTime":"18:11 EDT","volume":1869908,"amount":114965930.48385601,"timestamp":1784067070096,"change":0.17,"changeRate":0.002757,"amplitude":0.002757},"volumeRatio":3.497851,"impliedVol":0.3917,"impliedVolPercentile":0.8486},"requestUrl":"/m/hq/s/GEHC","defaultTab":"news","newsList":[{"id":"1178688255","title":"异动解读｜GE医疗盘中下跌6.29%，报61.2美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178688255","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178688255?lang=zh_cn&edition=full","pubTime":"2026-07-15 00:15","pubTimestamp":1784045754,"startTime":"0","endTime":"0","summary":"7月14日，GE医疗盘中下跌6.29%，报61.2美元/股，成交额2.75亿美元。GE医疗所在的医疗保健设备行业整体承压，个股中，直觉外科公司跌6.57%，史赛克跌6.52%，波士顿科学跌4.23%，雅培跌2.9%，美敦力跌4.83%。GE HealthCare Technologies Inc.是全球领先的医疗解决方案提供商，提供先进的医疗技术、药物诊断以及人工智能云和软件解决方案，服务覆盖超过160个国家的客户。公司下次财报将于7月29日盘前发布，预期每股收益1.04美元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101778527","title":"GE医疗与梅奥诊所携手推进新型诊疗一体化研究合作 旨在革新个性化癌症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1101778527","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101778527?lang=zh_cn&edition=full","pubTime":"2026-07-08 21:02","pubTimestamp":1783515727,"startTime":"0","endTime":"0","summary":"GE医疗与梅奥诊所宣布建立一项新的诊疗一体化研究合作关系，双方共同致力于推动个性化癌症治疗领域的进步。\n此次合作将聚焦于诊疗一体化领域，这是一种将诊断与靶向治疗相结合的前沿医疗模式。双方旨在通过整合GE医疗在成像技术、药物发现与数据分析方面的专长，以及梅奥诊所世界级的临床研究能力与患者护理经验，加速开发更精准、有效的癌症治疗方案。\n该合作伙伴关系期望能推动针对特定癌症类型的创新疗法研发，最终目标是为患者提供高度个性化的治疗选择，从而改善治疗效果并提升患者生活质量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","LGHT","GEHC","BK4588","BK4585","BK4082","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189041437","title":"FDA发布早期预警：通用电气医疗婴儿复苏系统存潜在高风险","url":"https://stock-news.laohu8.com/highlight/detail?id=1189041437","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189041437?lang=zh_cn&edition=full","pubTime":"2026-06-06 02:54","pubTimestamp":1780685652,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）下属的器械与放射健康中心（CDRH）发布了一项早期预警，旨在向公众通报通用电气医疗（GE Healthcare）旗下婴儿复苏系统可能存在的潜在高风险问题。该警示要求相关方提高警惕，并关注后续的官方安全通告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","BK4585","GEHC","LU0124676726.USD","BK4082","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167179961","title":"GE Healthcare获FDA 510(k)许可推出Mim Contour ProtÉGÉAI+ 2.0，拓展临床能力推进AI赋能放疗规划","url":"https://stock-news.laohu8.com/highlight/detail?id=1167179961","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167179961?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:59","pubTimestamp":1780574357,"startTime":"0","endTime":"0","summary":"GE Healthcare Technologies Inc  宣布，其Mim Contour ProtGAI+ 2.0已获得美国食品药品监督管理局的510许可。这一进展标志着该公司在人工智能驱动的放射治疗规划领域迈出了重要一步，新版本带来了显著扩展的临床功能。此次升级旨在通过增强的AI工具优化治疗流程，提升精度与效率。随着医疗AI应用的不断深入，GE Healthcare此次获批进一步巩固了其在放射治疗解决方案市场的地位。该产品有望帮助医疗机构缩短规划时间，改善患者治疗效果，推动精准肿瘤治疗的发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4082","LU0689626769.HKD","GEHC","BK4588","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141182902","title":"2026年欧洲放射治疗与肿瘤学会年会：GE医疗将重点展示AI赋能解决方案，推动放射治疗与影像引导介入领域的精准医疗发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1141182902","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141182902?lang=zh_cn&edition=full","pubTime":"2026-05-12 21:01","pubTimestamp":1778590875,"startTime":"0","endTime":"0","summary":"在即将举行的2026年欧洲放射治疗与肿瘤学会（ESTRO）年会上，GE医疗技术公司计划重点推介其人工智能赋能的创新解决方案。这些方案旨在显著提升放射治疗与影像引导介入治疗两大关键领域的精准医疗水平。通过展示前沿技术，GE医疗期望推动肿瘤诊疗的个性化与精确度迈向新台阶。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","BK4082","GEHC","BK4588","LU0689626769.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126155996","title":"GE医疗首席财务官詹姆斯·萨卡罗申报于5月1日以每股60.5997美元均价公开市场购入3310股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1126155996","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126155996?lang=zh_cn&edition=full","pubTime":"2026-05-01 23:48","pubTimestamp":1777650503,"startTime":"0","endTime":"0","summary":"根据最新提交的美国证券交易委员会（SEC）文件披露，GE Healthcare Technologies Inc（GEHC）首席财务官詹姆斯·萨卡罗于5月1日在公开市场完成一笔股票交易。记录显示，萨卡罗以每股60.5997美元的平均价格，合计购入3310股公司普通股。\n此次交易通过公开市场操作执行，凸显了公司管理层对GE医疗未来增长前景的信心。公开市场购买行为往往被投资者视为内部人士看好企业价值的积极信号。\n根据监管规定，上市公司高管及董事的股权交易需及时向SEC报备，以确保市场信息的透明度和公平性。此次交易细节已通过正式文件向监管机构报备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","BK4588","BK4082","GEHC","BK4585","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181888267","title":"异动解读 | 财报不及预期并下调盈利指引，GE医疗盘中大跌11.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181888267","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181888267?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:46","pubTimestamp":1777470403,"startTime":"0","endTime":"0","summary":"GE医疗科技公司今日盘中大跌11.55%，引发了市场的广泛关注。消息面上，公司发布的2026年第一季度财报显示，经调整后每股收益为0.99美元，低于分析师预期的1.05美元。同时，公司因通胀导致的成本压力下调了全年利润预期，将2026年调整后每股收益指引从原先的4.95-5.15美元下调至4.80-5.00美元。此外，第一季度利润还受到诊断业务中供应商问题的影响，不过公司表示该问题现已得到解决。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GEHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108571432","title":"GE医疗高管称：光子计数CT上市前 公司全球CT市场表现强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=1108571432","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108571432?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:19","pubTimestamp":1777468771,"startTime":"0","endTime":"0","summary":"在近期举行的电话会议上，GE医疗科技公司高管透露，即便在革命性的光子计数CT技术正式推向市场之前，该公司在全球计算机断层扫描（CT）市场的业务表现已然十分出色。\n高管强调，公司凭借现有的产品组合和市场策略，已在全球CT领域占据了有利竞争地位，为未来新技术的成功商业化奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEHC","BK4588","BK4585","LU0124676726.USD","BK4082","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187855726","title":"GE医疗高管称AI技术将推动传统CT设备实现低成本分辨率升级","url":"https://stock-news.laohu8.com/highlight/detail?id=1187855726","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187855726?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:17","pubTimestamp":1777468642,"startTime":"0","endTime":"0","summary":"在最新电话会议中，GE医疗技术公司高管透露，人工智能技术的持续进步将为传统计算机断层扫描设备带来革新性突破。通过AI算法的优化升级，现有CT设备有望以显著降低的成本实现图像分辨率的跨越式提升。\n这一技术路径将打破传统硬件升级的局限性，使医疗机构无需投入巨额资金更换核心设备即可获得更精准的影像诊断能力。人工智能与医疗影像的深度融合，正重新定义医学影像设备的生命周期管理策略。\n值得注意的是，该技术方案特别适用于预算有限但追求诊断质量提升的医疗场景。通过软件层面的智能优化，既能延续现有设备的使用价值，又能满足临床诊断对图像精度日益增长的需求，为医疗资源优化配置提供全新思路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","BK4082","BK4585","GEHC","LU0689626769.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513433","title":"GE医疗(GEHC)一季度每股收益0.85美元低于预期 盘前股价跌逾7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513433","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631513433?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:20","pubTimestamp":1777461650,"startTime":"0","endTime":"0","summary":"金吾财讯 | GE医疗 周三发布2026年一季度财报，业绩表现喜忧参半，受供应商问题影响盈利能力不及预期，公司下调全年调整后每股收益指引，同时宣布高管团队调整。财报显示，一季度 GE医疗实现销售额51.3亿美元，同比增长7.4%，高于市场预期的50.3亿美元；实现净利润3.89亿美元，合每股收益0.85美元，同比下滑31%。由于内存芯片、石油及运费成本上涨，GE医疗将全年调整后每股收益指引从4.95-5.15美元下调至4.80-5.00美元，营收增长指引维持3%-4%不变。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/NDEzNGMxNzgxNjk0YjcxNTczNmY1MTEwODUxNDQzMTc3Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDEzNGMxNzgxNjk0YjcxNTczNmY1MTEwODUxNDQzMTc3Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299836","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","BK4566","LU0267386448.USD","LU0354030511.USD","LU2168564222.USD","LU1066051225.USD","159891","LU1064131342.USD","LU1066051811.HKD","LU1093756168.USD","LU0353189763.USD","LU1280957306.USD","UDN","BK4187","GEHC","LU0124676726.USD","LU0943347566.SGD","LU1551013425.SGD","LU1988902786.USD","LU2264538146.SGD","BK4082","LU0157215616.USD","UUP","LU1084165304.USD","LU0868494617.USD","LU1119994496.HKD","GE","LU1366333091.USD","LU2756315664.SGD","LU2168564149.EUR","BK4543","LU0353189680.USD","LU2168564495.EUR","LU0689472784.USD","BK4585","BK4588","LU2543165471.USD","LU1093756325.SGD","LU1066053197.SGD","LU0820561909.HKD","LU2087625088.SGD","LU2756315318.SGD","LU0077335932.USD","LU1551013342.USD","LU0689626769.HKD","BK4206","LU0640476718.USD","LU1366192091.USD","BK4501","LU2168563687.JPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179496109","title":"更正：GE医疗科技一季度自由现金流为1.12亿美元（非“调整后自由现金流2.9亿美元”）","url":"https://stock-news.laohu8.com/highlight/detail?id=1179496109","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179496109?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:33","pubTimestamp":1777458801,"startTime":"0","endTime":"0","summary":"GE医疗科技公司最新公布的第一季度财务数据出现修正。经核实，该公司当期自由现金流实际为1.12亿美元，与此前误报的“调整后自由现金流2.9亿美元”存在显著差异。此次修正涉及关键财务指标，对投资者准确评估企业流动性状况具有重要影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","BK4082","BK4585","LU0689626769.HKD","GEHC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170044222","title":"GE医疗科技：对华审慎展望不变 中东冲突对营收影响微乎其微——发布会实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1170044222","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170044222?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:30","pubTimestamp":1777458636,"startTime":"0","endTime":"0","summary":"通用电气医疗科技公司在最新发布会上明确表态，其对中国市场持久的审慎经营展望并未发生任何实质性转变。与此同时，公司高管强调，当前中东地区的紧张局势对整体营收产生的冲击极其有限，几乎可以忽略不计。这一声明稳定了投资者情绪，凸显出公司全球业务布局的风险抵御能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GEHC","BK4588","BK4585","LU0124676726.USD","BK4082","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169272653","title":"GE医疗科技一季度通胀格局剧变 预计2026年投入成本激增约2.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169272653","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169272653?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:27","pubTimestamp":1777458432,"startTime":"0","endTime":"0","summary":"通用电气医疗科技公司披露，今年第一季度通胀环境发生显著变化，这将导致2026年预期投入成本增加约2.5亿美元。通胀压力的重新评估主要源于全球供应链波动及原材料价格走势超预期。尽管面临成本压力，该公司表示正通过运营效率优化和战略性采购调整来缓解影响。医疗科技行业整体正密切关注通胀动态对利润率的影响，而GE医疗作为全球领先的医疗设备供应商，其成本管控策略将成为市场关注焦点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","BK4082","BK4588","LU0689626769.HKD","BK4585","GEHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159389093","title":"GE医疗积极通过提价应对通胀 2027年影响料将加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1159389093","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159389093?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:27","pubTimestamp":1777458432,"startTime":"0","endTime":"0","summary":"通用电气医疗正积极采取价格调整策略，以抵消通胀带来的成本压力。公司表示将在可行范围内实施涨价措施，预计2027年此类举措的影响将进一步扩大。\n面对当前的经济环境，该医疗科技巨头正在通过灵活的定价机制维持盈利能力。分析指出，医疗行业特有的刚性需求为企业提供了价格调整空间，但具体实施效果仍需观察市场接受度。\n业内人士预测，随着全球医疗设备市场持续增长，GE医疗的战略性调价或将在中长期显现更显著成效。公司未来两年的财务表现将备受投资者关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","GEHC","BK4588","LU0124676726.USD","BK4585","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134000958","title":"GE医疗科技宣布高管团队与运营调整 强化执行力、加速创新、驱动增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1134000958","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134000958?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:24","pubTimestamp":1777458254,"startTime":"0","endTime":"0","summary":"GE医疗科技公司公布全新高管团队架构与运营优化方案，旨在全面提升战略执行力、加快创新技术孵化进程，并构建可持续增长新动能。此次调整聚焦于优化决策流程、整合跨部门资源，通过精细化运营模式强化市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","LU0689626769.HKD","BK4585","GEHC","BK4588","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151755029","title":"GE医疗下调盈利预期 但料通过定价与成本措施抵消过半通胀冲击","url":"https://stock-news.laohu8.com/highlight/detail?id=1151755029","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151755029?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:23","pubTimestamp":1777458218,"startTime":"0","endTime":"0","summary":"GE医疗科技公司宣布调整其利润展望，承认当前通胀环境对业绩构成压力。然而该公司强调，已通过战略性定价调整和成本优化措施，预计能够消化超过50%的通胀影响。\n管理层表示，虽然整体盈利预期有所下调，但通过主动的价格管理机制和运营效率提升，公司展现了较强的抗风险能力。这些举措有助于缓解原材料成本上升和供应链压力带来的经营挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","GEHC","BK4585","LU0689626769.HKD","BK4588","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140363725","title":"GE医疗科技首季内存芯片、石油及货运成本激增 预计将影响2026年剩余业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1140363725","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140363725?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:23","pubTimestamp":1777458195,"startTime":"0","endTime":"0","summary":"GE医疗科技公司披露，2026年第一季度面临内存芯片、石油和货运成本的显著上涨。这些成本压力预计将持续影响公司2026年剩余时间的财务表现。\n尽管面临成本挑战，公司仍在评估供应链优化方案以缓解冲击。市场关注其能否通过技术创新和运营效率提升来抵消成本上涨的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","GEHC","LU0689626769.HKD","BK4588","BK4585","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155579651","title":"GE医疗重申2026财年增长预期 全球终端市场需求稳健支撑营收扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=1155579651","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155579651?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:22","pubTimestamp":1777458137,"startTime":"0","endTime":"0","summary":"GE医疗科技公司最新宣布，维持对2026财年整体营收增长目标的预测。这一乐观展望主要得益于全球医疗设备终端市场持续健康的需求态势。\n公司强调，其核心业务板块在全球范围内呈现稳定增长动力。从医学影像到生命科学解决方案，各细分领域的需求韧性为业绩增长提供了有力支撑。随着医疗数字化和精准诊疗趋势的深化，公司对中长期市场前景保持积极态度。\n此次重申业绩指引，彰显了管理层对业务基本面的信心。在全球医疗支出稳步增长的背景下，公司通过技术创新和全球布局，持续捕捉市场机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","GEHC","BK4585","LU0689626769.HKD","BK4588","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103050250","title":"GE医疗季度盈利能力受单一供应商问题影响 该问题现已解决","url":"https://stock-news.laohu8.com/highlight/detail?id=1103050250","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103050250?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:22","pubTimestamp":1777458135,"startTime":"0","endTime":"0","summary":"GE医疗科技公司本季度盈利能力受到一项特定供应商问题的暂时性影响。这一涉及PDx系统的供应中断问题目前已经得到圆满解决，公司运营已恢复正常轨道。\n此次事件虽对短期财务表现造成波动，但并未动摇公司的基本面。管理层表示，通过快速响应和供应链优化，相关问题已得到彻底处理，不会对未来的业务发展产生持续性影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LU0689626769.HKD","BK4082","GEHC","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198052763","title":"GE医疗启动锰基MRI造影剂Lumina试验II/III期临床研究 首位患者用药获FDA快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1198052763","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198052763?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:29","pubTimestamp":1776943757,"startTime":"0","endTime":"0","summary":"GE HEALTHCARE TECHNOLOGIES INC宣布，其创新锰基核磁共振造影剂的Lumina试验已进入II/III期临床阶段，首位患者完成给药。该项目获得美国食品药品监督管理局快速通道资格认定，标志着公司新型影像剂研发管线取得重要进展。此次突破性进展将加速推进该造影剂的临床开发进程。FDA快速通道资格将促进该药物与监管机构的密切沟通，并可能缩短审批时间。该里程碑事件进一步巩固了公司在医学影像创新领域的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GEHC","LU0689626769.HKD","BK4585","LU0124676726.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://gehealthcare.com;investor.gehealthcare.com","stockEarnings":[{"period":"1week","weight":0.0072},{"period":"1month","weight":0.002},{"period":"3month","weight":-0.1254},{"period":"6month","weight":-0.2343},{"period":"1year","weight":-0.1307},{"period":"ytd","weight":-0.2037}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.01},{"period":"3month","weight":0.0788},{"period":"6month","weight":0.0852},{"period":"1year","weight":0.2013},{"period":"ytd","weight":0.0986}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GE HealthCare Technologies Inc.于2022年5月16日作为特拉华州有限责任公司成立。该公司是全球领先的医疗解决方案提供商，提供先进的医疗技术、药物诊断以及人工智能云和软件解决方案。其服务覆盖超过160个国家的客户，致力于提供旨在实现更个性化和精准患者护理的创新技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.013681},{"month":2,"riseRate":0.75,"avgChangeRate":0.09846},{"month":3,"riseRate":0.25,"avgChangeRate":-0.039015},{"month":4,"riseRate":0,"avgChangeRate":-0.110914},{"month":5,"riseRate":0.75,"avgChangeRate":0.007057},{"month":6,"riseRate":0.75,"avgChangeRate":0.024391},{"month":7,"riseRate":0.5,"avgChangeRate":0.007353},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.020253},{"month":9,"riseRate":0.666667,"avgChangeRate":0.030278},{"month":10,"riseRate":0,"avgChangeRate":-0.030954},{"month":11,"riseRate":0.666667,"avgChangeRate":0.016118},{"month":12,"riseRate":0.666667,"avgChangeRate":0.031412}],"exchange":"NASDAQ","name":"GE HEALTHCARE TECHNOLOGIES INC","nameEN":"GE HEALTHCARE TECHNOLOGIES INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GE HEALTHCARE TECHNOLOGIES INC(GEHC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GE HEALTHCARE TECHNOLOGIES INC(GEHC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GE HEALTHCARE TECHNOLOGIES INC,GEHC,GE HEALTHCARE TECHNOLOGIES INC股票,GE HEALTHCARE TECHNOLOGIES INC股票老虎,GE HEALTHCARE TECHNOLOGIES INC股票老虎国际,GE HEALTHCARE TECHNOLOGIES INC行情,GE HEALTHCARE TECHNOLOGIES INC股票行情,GE HEALTHCARE TECHNOLOGIES INC股价,GE HEALTHCARE TECHNOLOGIES INC股市,GE HEALTHCARE TECHNOLOGIES INC股票价格,GE HEALTHCARE TECHNOLOGIES INC股票交易,GE HEALTHCARE TECHNOLOGIES INC股票购买,GE HEALTHCARE TECHNOLOGIES INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GE HEALTHCARE TECHNOLOGIES INC(GEHC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GE HEALTHCARE TECHNOLOGIES INC(GEHC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}